ALK and non-small cell lung carcinoma: In addition, Pedrosa et al. recently published a summary of the potential molecular signatures associated with the development of BMs in NSCLC (e.g., certain miRNAs, lncRNAs, and EGFR/KRAS&ALK) [73].